DNAJC5 and metabolic dysfunction-associated steatohepatitis: These findings also suggest that CSP contributes to the progression of NASH in HFD-fed mice and that the mechanism may involve some microbial metabolites produced by bacteria with high abundance in CSP-treated mice.